Review



ecgm2 supplement mix  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    PromoCell ecgm2 supplement mix
    Ecgm2 Supplement Mix, supplied by PromoCell, used in various techniques. Bioz Stars score: 99/100, based on 1047 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecgm2 supplement mix/product/PromoCell
    Average 99 stars, based on 1047 article reviews
    ecgm2 supplement mix - by Bioz Stars, 2026-05
    99/100 stars

    Images



    Similar Products

    99
    PromoCell ecgm2 supplement mix
    Ecgm2 Supplement Mix, supplied by PromoCell, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ecgm2 supplement mix/product/PromoCell
    Average 99 stars, based on 1 article reviews
    ecgm2 supplement mix - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    96
    PromoCell supplement mix ecgm2
    Protrudin regulates angiogenic tube formation in vitro. a HUVECs were transduced for 48 h with shRNA lentiviruses targeting Protrudin (shProtrudin) or a non-targeting shRNA (shNT). Cells were seeded in triplicate on the Millipore matrix in a 96-well plate containing <t>ECGM2</t> complete media and incubated for 5 h. Phase contrast images were then taken of the tubes formed, 4 fields from each well. The experiment was done four times, a total of at least 40 fields per condition were imaged. Representative images are shown. b Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in control versus Protrudin knockdown cells. Data represent mean ± SD of four independent experiments, two-tailed Student’s t -test. ** p < 0.01. c HUVECs were transduced with shProtrudin + Mock lentivirus or shProtrudin + Protrudin-wild-type rescue lentivirus (shProtrudin + Prot.WTres) and then seeded on a Millipore matrix for tube formation assay as described in ( a ). d Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in shProtrudin + Mock versus shProtrudin + Prot.WTres cells. Data represent mean ± SD of four independent experiments, two-tailed Student’s t -test. ** p < 0.01. e HUVECs were transduced with either empty (Mock) or Protrudin (wild-type or domain-deleted) lentiviral constructs for 48 h. Cells were then trypsinized and seeded on the Millipore matrix as described in ( a ). Experiment was done thrice with wells seeded in triplicate per sample each time; representative images are shown. Scale bar = 1000 μm. f Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in control vs. Protrudin wild-type or domain-deleted protein expressing samples as indicated. Data represent mean ± SD of three independent experiments. One-way ANOVA followed by Dunnett’s multiple comparisons test * p < 0.05, ** p < 0.01, *** p < 0.001 as compared to Mock
    Supplement Mix Ecgm2, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/supplement mix ecgm2/product/PromoCell
    Average 96 stars, based on 1 article reviews
    supplement mix ecgm2 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    Protrudin regulates angiogenic tube formation in vitro. a HUVECs were transduced for 48 h with shRNA lentiviruses targeting Protrudin (shProtrudin) or a non-targeting shRNA (shNT). Cells were seeded in triplicate on the Millipore matrix in a 96-well plate containing ECGM2 complete media and incubated for 5 h. Phase contrast images were then taken of the tubes formed, 4 fields from each well. The experiment was done four times, a total of at least 40 fields per condition were imaged. Representative images are shown. b Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in control versus Protrudin knockdown cells. Data represent mean ± SD of four independent experiments, two-tailed Student’s t -test. ** p < 0.01. c HUVECs were transduced with shProtrudin + Mock lentivirus or shProtrudin + Protrudin-wild-type rescue lentivirus (shProtrudin + Prot.WTres) and then seeded on a Millipore matrix for tube formation assay as described in ( a ). d Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in shProtrudin + Mock versus shProtrudin + Prot.WTres cells. Data represent mean ± SD of four independent experiments, two-tailed Student’s t -test. ** p < 0.01. e HUVECs were transduced with either empty (Mock) or Protrudin (wild-type or domain-deleted) lentiviral constructs for 48 h. Cells were then trypsinized and seeded on the Millipore matrix as described in ( a ). Experiment was done thrice with wells seeded in triplicate per sample each time; representative images are shown. Scale bar = 1000 μm. f Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in control vs. Protrudin wild-type or domain-deleted protein expressing samples as indicated. Data represent mean ± SD of three independent experiments. One-way ANOVA followed by Dunnett’s multiple comparisons test * p < 0.05, ** p < 0.01, *** p < 0.001 as compared to Mock

    Journal: Cellular and Molecular Life Sciences

    Article Title: Protrudin regulates FAK activation, endothelial cell migration and angiogenesis

    doi: 10.1007/s00018-022-04251-z

    Figure Lengend Snippet: Protrudin regulates angiogenic tube formation in vitro. a HUVECs were transduced for 48 h with shRNA lentiviruses targeting Protrudin (shProtrudin) or a non-targeting shRNA (shNT). Cells were seeded in triplicate on the Millipore matrix in a 96-well plate containing ECGM2 complete media and incubated for 5 h. Phase contrast images were then taken of the tubes formed, 4 fields from each well. The experiment was done four times, a total of at least 40 fields per condition were imaged. Representative images are shown. b Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in control versus Protrudin knockdown cells. Data represent mean ± SD of four independent experiments, two-tailed Student’s t -test. ** p < 0.01. c HUVECs were transduced with shProtrudin + Mock lentivirus or shProtrudin + Protrudin-wild-type rescue lentivirus (shProtrudin + Prot.WTres) and then seeded on a Millipore matrix for tube formation assay as described in ( a ). d Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in shProtrudin + Mock versus shProtrudin + Prot.WTres cells. Data represent mean ± SD of four independent experiments, two-tailed Student’s t -test. ** p < 0.01. e HUVECs were transduced with either empty (Mock) or Protrudin (wild-type or domain-deleted) lentiviral constructs for 48 h. Cells were then trypsinized and seeded on the Millipore matrix as described in ( a ). Experiment was done thrice with wells seeded in triplicate per sample each time; representative images are shown. Scale bar = 1000 μm. f Bar diagram demonstrating quantification of the number of tubes, the length of tubes, and the number of loops in control vs. Protrudin wild-type or domain-deleted protein expressing samples as indicated. Data represent mean ± SD of three independent experiments. One-way ANOVA followed by Dunnett’s multiple comparisons test * p < 0.05, ** p < 0.01, *** p < 0.001 as compared to Mock

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) and Endothelial Cell Medium 2 (ECM2) along with the supplement mix (ECGM2) were obtained from PromoCell (Heidelberg, DE).

    Techniques: In Vitro, shRNA, Incubation, Two Tailed Test, Transduction, Tube Formation Assay, Construct, Expressing

    Protrudin regulates late endosome/lysosome (LE/Lys) distribution and protrusion formation in endothelial cells. a Deconvolved confocal microscopic images of HUVECs expressing electroporated plasmid constructs encoding GFP (control), Protrudin-GFP (Protrudin-WT) or KIF-binding domain-deleted Protrudin-GFP (Protrudin-ΔKIF). After 24 h of transfection in ECGM2 complete media, cells were fixed in 4% PFA and immunostained with anti-Lamp1 antibody. The insert highlights dispersed Lamp1 vesicles colocalized with Protrudin-WT representing ER-endosome contact sites. Scale bar = 20 μm. b Quantification of protrusion formation in HUVECs transfected as in ( a ). Data represent mean ± SD of four independent experiments (200 cells per condition), one-way ANOVA followed by Tukey’s multiple comparisons test. *** p < 0.001 as compared to EGFP transfected control, ### p < 0.001 as compared to Protrudin-WT. c Quantification of perinuclear distributed Lamp1-positive LE/Lys in HUVECs transfected as in ( a ). Bars represent the percentage of perinuclear Lamp1 vesicles from total Lamp1-positive vesicles in a cell. Data represent mean ± SD of four independent experiments. One-way ANOVA followed by Tukey’s multiple comparisons test ** p < 0.01 as compared to EGFP transfected sample, ### p < 0.001 as compared to Protrudin-WT

    Journal: Cellular and Molecular Life Sciences

    Article Title: Protrudin regulates FAK activation, endothelial cell migration and angiogenesis

    doi: 10.1007/s00018-022-04251-z

    Figure Lengend Snippet: Protrudin regulates late endosome/lysosome (LE/Lys) distribution and protrusion formation in endothelial cells. a Deconvolved confocal microscopic images of HUVECs expressing electroporated plasmid constructs encoding GFP (control), Protrudin-GFP (Protrudin-WT) or KIF-binding domain-deleted Protrudin-GFP (Protrudin-ΔKIF). After 24 h of transfection in ECGM2 complete media, cells were fixed in 4% PFA and immunostained with anti-Lamp1 antibody. The insert highlights dispersed Lamp1 vesicles colocalized with Protrudin-WT representing ER-endosome contact sites. Scale bar = 20 μm. b Quantification of protrusion formation in HUVECs transfected as in ( a ). Data represent mean ± SD of four independent experiments (200 cells per condition), one-way ANOVA followed by Tukey’s multiple comparisons test. *** p < 0.001 as compared to EGFP transfected control, ### p < 0.001 as compared to Protrudin-WT. c Quantification of perinuclear distributed Lamp1-positive LE/Lys in HUVECs transfected as in ( a ). Bars represent the percentage of perinuclear Lamp1 vesicles from total Lamp1-positive vesicles in a cell. Data represent mean ± SD of four independent experiments. One-way ANOVA followed by Tukey’s multiple comparisons test ** p < 0.01 as compared to EGFP transfected sample, ### p < 0.001 as compared to Protrudin-WT

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) and Endothelial Cell Medium 2 (ECM2) along with the supplement mix (ECGM2) were obtained from PromoCell (Heidelberg, DE).

    Techniques: Expressing, Plasmid Preparation, Construct, Binding Assay, Transfection

    Protrudin promotes endothelial cell migration. a Representative images of wound closure in HUVECs transduced with Protrudin knockdown or non-targeting lentivirus in ECGM2 complete media, at t = 0 and t = 22 h. Scale bar = 300 μm. b Line diagram representing cell migration profile of HUVECs towards the wounded area over a period of 22 h. The bar graph represents relative wound density (%) in control (shNT) vs. Protrudin knockdown HUVECs for three independent experiments; two-tailed Student’s t-test, * p < 0.05. Data represent mean ± SD. c Wound-healing assay using HUVECs overexpressing Protrudin wild-type (Protrudin-WT) or Mock (Control) lentiviral construct. At 48 h post-transduction, a wound was made in confluent monolayers and cells were imaged for 24 h. Representative images at t = 0 and t = 24 h are shown. Scale bar = 300 μm. d Line diagram representing cell migration profile of HUVECs towards the wounded area over a period of 24 h. The bar graph represents relative wound density (%) in Mock vs. Protrudin overexpressing HUVECs. Data represent mean ± SD, * p < 0.05. e Migration profile of shProtrudin HUVECs compared to shNT (non-targeting shRNA) cells measured in real-time using an impedance-based migration assay on xCELLigence RCTA DP instrument. Bar graph representing migration cell index in Control (shNT) vs. Protrudin knockdown HUVECs at 12 h. Experiment was done thrice. Data represent mean ± SD, two-tailed Student’s t -test ** p < 0.01

    Journal: Cellular and Molecular Life Sciences

    Article Title: Protrudin regulates FAK activation, endothelial cell migration and angiogenesis

    doi: 10.1007/s00018-022-04251-z

    Figure Lengend Snippet: Protrudin promotes endothelial cell migration. a Representative images of wound closure in HUVECs transduced with Protrudin knockdown or non-targeting lentivirus in ECGM2 complete media, at t = 0 and t = 22 h. Scale bar = 300 μm. b Line diagram representing cell migration profile of HUVECs towards the wounded area over a period of 22 h. The bar graph represents relative wound density (%) in control (shNT) vs. Protrudin knockdown HUVECs for three independent experiments; two-tailed Student’s t-test, * p < 0.05. Data represent mean ± SD. c Wound-healing assay using HUVECs overexpressing Protrudin wild-type (Protrudin-WT) or Mock (Control) lentiviral construct. At 48 h post-transduction, a wound was made in confluent monolayers and cells were imaged for 24 h. Representative images at t = 0 and t = 24 h are shown. Scale bar = 300 μm. d Line diagram representing cell migration profile of HUVECs towards the wounded area over a period of 24 h. The bar graph represents relative wound density (%) in Mock vs. Protrudin overexpressing HUVECs. Data represent mean ± SD, * p < 0.05. e Migration profile of shProtrudin HUVECs compared to shNT (non-targeting shRNA) cells measured in real-time using an impedance-based migration assay on xCELLigence RCTA DP instrument. Bar graph representing migration cell index in Control (shNT) vs. Protrudin knockdown HUVECs at 12 h. Experiment was done thrice. Data represent mean ± SD, two-tailed Student’s t -test ** p < 0.01

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) and Endothelial Cell Medium 2 (ECM2) along with the supplement mix (ECGM2) were obtained from PromoCell (Heidelberg, DE).

    Techniques: Migration, Transduction, Two Tailed Test, Wound Healing Assay, Construct, shRNA

    Knockdown of Protrudin promotes perinuclear accumulation of mTOR-positive LE/Lys and diminished mTORC1 activity. a Deconvolved confocal micrographs showing distribution of mTOR-positive LE/Lys. HUVECs were seeded on glass coverslips along with lentivirus carrying shProtrudin, shProtrudin#2 or shNT sequence and cells were grown in ECGM2 complete media. Post-transduction, the cells were fixed in 4% PFA and immunostained with anti-Lamp1 and anti-mTOR antibodies. Experiment was done thrice, and the data are representative of at least 15 image captures for each condition per experiment. The high-magnification inset on the right illustrates dispersed mTOR-Lamp1-positive endosomes. b Quantification of perinuclear distributed mTOR-positive lysosomes. Graph represents percentage intensities of perinuclearly distributed mTOR relative to total cellular mTOR-positive vesicles. 150 cells per condition were analyzed from 3 independent experiments. Data represent mean ± SD for 3 independent experiments. * p < 0.05 as compared to control samples. c Immunoblots showing phosphorylation level of S6K in Protrudin knockdown HUVECs grown in complete media. d Immunoblots of Protrudin knockdown or control cells showing the phosphorylation level of S6K. Cells were serum starved in 0.1% BSA for 5 h followed by stimulation with ( +) or without ( −) VEGF (50 ng/ml) for 20 min. Cells were lysed and immunoblotted with total or phospho-p70S6K (Thr 389) antibodies. Data represent mean ± SD for 5 independent experiments. * p < 0.05 as compared to shNT, − VEGF samples # p < 0.05 compared to shNT, + VEGF samples. d Immunoblots showing the phosphorylation level of Akt(Ser473) in Protrudin knockdown HUVECs as described in ( c ). Graphs represent relative densitometric values of pAkt(Ser473) normalized to Akt. Data represent mean ± SD for 3 independent experiments. n.s. indicates statistically not significant compared to shNT, − VEGF samples or shNT, + VEGF samples

    Journal: Cellular and Molecular Life Sciences

    Article Title: Protrudin regulates FAK activation, endothelial cell migration and angiogenesis

    doi: 10.1007/s00018-022-04251-z

    Figure Lengend Snippet: Knockdown of Protrudin promotes perinuclear accumulation of mTOR-positive LE/Lys and diminished mTORC1 activity. a Deconvolved confocal micrographs showing distribution of mTOR-positive LE/Lys. HUVECs were seeded on glass coverslips along with lentivirus carrying shProtrudin, shProtrudin#2 or shNT sequence and cells were grown in ECGM2 complete media. Post-transduction, the cells were fixed in 4% PFA and immunostained with anti-Lamp1 and anti-mTOR antibodies. Experiment was done thrice, and the data are representative of at least 15 image captures for each condition per experiment. The high-magnification inset on the right illustrates dispersed mTOR-Lamp1-positive endosomes. b Quantification of perinuclear distributed mTOR-positive lysosomes. Graph represents percentage intensities of perinuclearly distributed mTOR relative to total cellular mTOR-positive vesicles. 150 cells per condition were analyzed from 3 independent experiments. Data represent mean ± SD for 3 independent experiments. * p < 0.05 as compared to control samples. c Immunoblots showing phosphorylation level of S6K in Protrudin knockdown HUVECs grown in complete media. d Immunoblots of Protrudin knockdown or control cells showing the phosphorylation level of S6K. Cells were serum starved in 0.1% BSA for 5 h followed by stimulation with ( +) or without ( −) VEGF (50 ng/ml) for 20 min. Cells were lysed and immunoblotted with total or phospho-p70S6K (Thr 389) antibodies. Data represent mean ± SD for 5 independent experiments. * p < 0.05 as compared to shNT, − VEGF samples # p < 0.05 compared to shNT, + VEGF samples. d Immunoblots showing the phosphorylation level of Akt(Ser473) in Protrudin knockdown HUVECs as described in ( c ). Graphs represent relative densitometric values of pAkt(Ser473) normalized to Akt. Data represent mean ± SD for 3 independent experiments. n.s. indicates statistically not significant compared to shNT, − VEGF samples or shNT, + VEGF samples

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) and Endothelial Cell Medium 2 (ECM2) along with the supplement mix (ECGM2) were obtained from PromoCell (Heidelberg, DE).

    Techniques: Activity Assay, Sequencing, Transduction, Western Blot

    Knockdown of Protrudin impairs activation of focal adhesion kinase. HUVECs were transduced with Protrudin or non-targeting shRNA and incubated for 48 h followed by puromycin selection for 16 h in complete ECGM2 media. a Cells were lysed for immunoblotting using antibodies to pFAK(Tyr397) and GAPDH. The experiments were done thrice; a representative blot is shown. The bar diagram represents relative densitometric values of pFAK(Tyr397) normalized for GAPDH. Data represent mean ± SD for three independent experiments, ** p < 0.01, compared to shNT. b Post-selection shNT or shProtrudin cells were serum-starved for 5 h in ECM2 media containing 0.1%BSA followed by stimulation without ( −) or with ( +) VEGF (50 ng/ml) for 5 min, and lysed for immunoblotting using antibodies to pFAK(Tyr397) (panel 1), total FAK (panel 2); Protrudin (panel 3), actin (panel 4); c pFAK(Tyr861) (upper panel), GAPDH (lower panel). The experiments were done thrice; representative blots are shown. The bar diagrams in ( b , c ) represent relative densitometric values of pFAK(Tyr397) or pFAK(Tyr861) normalized for total FAK and GAPDH, respectively. Data represent mean ± SD for three independent experiments, *** p < 0.001, * p < 0.05 compared to shNT without VEGF stimulation. ## p < 0.01 compared to shNT with VEGF stimulation. d HUVECs were transduced with shProtrudin#2 or non-targeting shRNA as described above for ( a ) and ( b ). Cells were lysed and immunoblotted with anti-pFAK(Tyr 397) (upper panel) or -actin (lower panel). The experiments were done thrice; a representative blot is shown. The bar diagram represents relative densitometric values of pFAK (Tyr397) normalized to actin. Data represent mean ± SD, * p < 0.05 compared to shNT without VEGF stimulation. # p < 0.05 compared to shNT with VEGF stimulation. e Human aortic endothelial cells (HAECs) were transduced with shProtrudin or non-targeting shRNA as described above. Cells were lysed and immunoblotted using antibodies against pFAK(Tyr 397) (upper panel) and GAPDH (lower panel). The experiments were done thrice; a representative blot is shown. The bar diagrams represent relative densitometric values of pFAK normalized to GAPDH. Data represent mean ± SD, * p < 0.05 compared to shNT without VEGF stimulation. ## p < 0.01 compared to shNT with VEGF stimulation. f Immunoblot showing cytoplasmic, endosomal and plasma membrane fractions of HUVEC transduced with shNT or shProtrudin, serum-starved for 5 h in medium with 0.1% BSA prior to subcellular fractionation as described in Methods. Data represent mean ± SD for three independent experiments, ** p < 0.01, n.s. indicates statistically not significant. The bar diagrams represent relative densitometric values of pFAK or FAK normalized to actin. g HUVECs were seeded on glass coverslips along with control or shProtrudin lentivirus for 48 h in ECGM2 complete media, followed by puromycin selection. Cells were then fixed and stained with Phalloidin-AlexaFluor 594 (actin) or anti-pFAK(Tyr861) and analyzed by confocal microscopy, followed by deconvolution. The experiment was done thrice, and the data are representative of at least 15 image captures per experiment. Bar diagram demonstrates quantification of the percentage of cells with actin stress fibers. 60 cells per condition were analyzed for the quantification, n = 3 independent experiments. Data represent mean ± SD. ** p < 0.01 compared to shNT, two-tailed Student’s t -test

    Journal: Cellular and Molecular Life Sciences

    Article Title: Protrudin regulates FAK activation, endothelial cell migration and angiogenesis

    doi: 10.1007/s00018-022-04251-z

    Figure Lengend Snippet: Knockdown of Protrudin impairs activation of focal adhesion kinase. HUVECs were transduced with Protrudin or non-targeting shRNA and incubated for 48 h followed by puromycin selection for 16 h in complete ECGM2 media. a Cells were lysed for immunoblotting using antibodies to pFAK(Tyr397) and GAPDH. The experiments were done thrice; a representative blot is shown. The bar diagram represents relative densitometric values of pFAK(Tyr397) normalized for GAPDH. Data represent mean ± SD for three independent experiments, ** p < 0.01, compared to shNT. b Post-selection shNT or shProtrudin cells were serum-starved for 5 h in ECM2 media containing 0.1%BSA followed by stimulation without ( −) or with ( +) VEGF (50 ng/ml) for 5 min, and lysed for immunoblotting using antibodies to pFAK(Tyr397) (panel 1), total FAK (panel 2); Protrudin (panel 3), actin (panel 4); c pFAK(Tyr861) (upper panel), GAPDH (lower panel). The experiments were done thrice; representative blots are shown. The bar diagrams in ( b , c ) represent relative densitometric values of pFAK(Tyr397) or pFAK(Tyr861) normalized for total FAK and GAPDH, respectively. Data represent mean ± SD for three independent experiments, *** p < 0.001, * p < 0.05 compared to shNT without VEGF stimulation. ## p < 0.01 compared to shNT with VEGF stimulation. d HUVECs were transduced with shProtrudin#2 or non-targeting shRNA as described above for ( a ) and ( b ). Cells were lysed and immunoblotted with anti-pFAK(Tyr 397) (upper panel) or -actin (lower panel). The experiments were done thrice; a representative blot is shown. The bar diagram represents relative densitometric values of pFAK (Tyr397) normalized to actin. Data represent mean ± SD, * p < 0.05 compared to shNT without VEGF stimulation. # p < 0.05 compared to shNT with VEGF stimulation. e Human aortic endothelial cells (HAECs) were transduced with shProtrudin or non-targeting shRNA as described above. Cells were lysed and immunoblotted using antibodies against pFAK(Tyr 397) (upper panel) and GAPDH (lower panel). The experiments were done thrice; a representative blot is shown. The bar diagrams represent relative densitometric values of pFAK normalized to GAPDH. Data represent mean ± SD, * p < 0.05 compared to shNT without VEGF stimulation. ## p < 0.01 compared to shNT with VEGF stimulation. f Immunoblot showing cytoplasmic, endosomal and plasma membrane fractions of HUVEC transduced with shNT or shProtrudin, serum-starved for 5 h in medium with 0.1% BSA prior to subcellular fractionation as described in Methods. Data represent mean ± SD for three independent experiments, ** p < 0.01, n.s. indicates statistically not significant. The bar diagrams represent relative densitometric values of pFAK or FAK normalized to actin. g HUVECs were seeded on glass coverslips along with control or shProtrudin lentivirus for 48 h in ECGM2 complete media, followed by puromycin selection. Cells were then fixed and stained with Phalloidin-AlexaFluor 594 (actin) or anti-pFAK(Tyr861) and analyzed by confocal microscopy, followed by deconvolution. The experiment was done thrice, and the data are representative of at least 15 image captures per experiment. Bar diagram demonstrates quantification of the percentage of cells with actin stress fibers. 60 cells per condition were analyzed for the quantification, n = 3 independent experiments. Data represent mean ± SD. ** p < 0.01 compared to shNT, two-tailed Student’s t -test

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) and Endothelial Cell Medium 2 (ECM2) along with the supplement mix (ECGM2) were obtained from PromoCell (Heidelberg, DE).

    Techniques: Activation Assay, Transduction, shRNA, Incubation, Selection, Western Blot, Fractionation, Staining, Confocal Microscopy, Two Tailed Test

    Knockdown of Raptor does not affect FAK activation or angiogenic tube formation in HUVECs. a Cells were transduced with lentivirus targeting Raptor or non-targeting control lentivirus (shNT) and incubated in complete ECGM2 growth media for 48 h. Transduced cells were selected with puromycin and lysed for Quantitative RT-PCR. b Post-selection Raptor knockdown and shNT cells were subjected to western immunoblotting and probed with anti-pFAK(Tyr397), anti-pS6K(Thr389) and anti-GAPDH antibody. c HUVECs were transduced with shNT or shRaptor lentivirus and then seeded on a Millipore matrix as described in Fig. a. d Bar diagram demonstrating quantification of the number of tubes and loops, as well as the length of tubes in shNT versus shRaptor cells. Data represent mean ± SD of three independent experiments, two-tailed Student’s t -test, n.s., statistically not significant

    Journal: Cellular and Molecular Life Sciences

    Article Title: Protrudin regulates FAK activation, endothelial cell migration and angiogenesis

    doi: 10.1007/s00018-022-04251-z

    Figure Lengend Snippet: Knockdown of Raptor does not affect FAK activation or angiogenic tube formation in HUVECs. a Cells were transduced with lentivirus targeting Raptor or non-targeting control lentivirus (shNT) and incubated in complete ECGM2 growth media for 48 h. Transduced cells were selected with puromycin and lysed for Quantitative RT-PCR. b Post-selection Raptor knockdown and shNT cells were subjected to western immunoblotting and probed with anti-pFAK(Tyr397), anti-pS6K(Thr389) and anti-GAPDH antibody. c HUVECs were transduced with shNT or shRaptor lentivirus and then seeded on a Millipore matrix as described in Fig. a. d Bar diagram demonstrating quantification of the number of tubes and loops, as well as the length of tubes in shNT versus shRaptor cells. Data represent mean ± SD of three independent experiments, two-tailed Student’s t -test, n.s., statistically not significant

    Article Snippet: Human umbilical vein endothelial cells (HUVECs) and Endothelial Cell Medium 2 (ECM2) along with the supplement mix (ECGM2) were obtained from PromoCell (Heidelberg, DE).

    Techniques: Activation Assay, Transduction, Incubation, Quantitative RT-PCR, Selection, Western Blot, Two Tailed Test